Metformin treats Fragile X syndrome symptoms in mice [PreClinical]
1. Following treatment with metformin, mouse models of Fragile X syndrome (FXS) demonstrated restored neurological signaling activity and synaptic function....
Corinne is an MD/PhD student and graduate of Spelman College. Currently a PhD candidate in Immunology, Corinne is studying the rare condition of STAT5B deficiency and its associated fatal pulmonary complications. She has fervent interests in nutrition, pediatrics, and education, and aims to combine these three interests along with rare disease research in her future career. When away from the lab, Corinne enjoys cooking, writing poetry, and getting lost in neosoul music.
1. Following treatment with metformin, mouse models of Fragile X syndrome (FXS) demonstrated restored neurological signaling activity and synaptic function....
1. Blood from liver transplant patients treated with a calcineurin inhibitor (CNI) showed increased levels of apoptotic regulatory T cells...
1. Thymosin α1 (Tα1), an immunomodulatory drug currently in use, decreased lung inflammation in a mouse model of cystic fibrosis...
1. Researchers manufactured a microfluidic biochip, using an inkjet printing system to apply conductive nanoparticles to a polymer substrate. 2....
1. A lipid nanoparticle (LNP) delivery system was developed to introduce factor IX (FIX) messenger RNA (mRNA) into a FIX...
1. Following treatment with glucocorticoids, human hematopoietic stem cells (HSCs) from cord blood demonstrated enhanced homing and engraftment to...
1. Müllerian inhibiting substance (MIS) was found to be a successful and safe contraceptive in female mice. 2. Female mice...
1. A gene alteration in the nicotinic acetylcholine receptor (nAChR) α5 subunit, previously found to be associated with schizophrenia, was...
1. Combining tumor-specific T cells and pathogen-based immune stimulation, reenergized adoptive cell transfer (ReACT) targeted and eradicated tumor cells...
1. A targeted immunoproteasome inhibitor, DPLG3, was found to have high selectivity for the immune cell proteasome and was...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.